BioCentury
ARTICLE | Company News

Aviron gains before PDUFA deadline

August 30, 2001 7:00 AM UTC

AVIR was up $0.49 to $23.40 on Thursday prior to Friday's Prescription Drug User Fee Act (PDUFA) deadline for its FluMist intranasal influenza vaccine. In July, the FDA's Vaccines and Related Biologic...